Repare Therapeutics Inc (RPTX)
3.57
+0.04
(+1.13%)
USD |
NASDAQ |
May 17, 16:00
3.57
0.00 (0.00%)
After-Hours: 20:00
Repare Therapeutics Price to Book Value: 0.6496 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.6496 |
| May 16, 2024 | 0.646 |
| May 15, 2024 | 0.6533 |
| May 14, 2024 | 0.6752 |
| May 13, 2024 | 0.6771 |
| May 10, 2024 | 0.6405 |
| May 09, 2024 | 0.6661 |
| May 08, 2024 | 0.6935 |
| May 07, 2024 | 0.6002 |
| May 06, 2024 | 0.6222 |
| May 03, 2024 | 0.6313 |
| May 02, 2024 | 0.613 |
| May 01, 2024 | 0.6039 |
| April 30, 2024 | 0.5673 |
| April 29, 2024 | 0.5856 |
| April 26, 2024 | 0.5856 |
| April 25, 2024 | 0.5764 |
| April 24, 2024 | 0.6039 |
| April 23, 2024 | 0.6149 |
| April 22, 2024 | 0.5966 |
| April 19, 2024 | 0.5764 |
| April 18, 2024 | 0.5526 |
| April 17, 2024 | 0.5874 |
| April 16, 2024 | 0.6112 |
| April 15, 2024 | 0.635 |
| Date | Value |
|---|---|
| April 12, 2024 | 0.6679 |
| April 11, 2024 | 0.7137 |
| April 10, 2024 | 0.721 |
| April 09, 2024 | 0.721 |
| April 08, 2024 | 0.7393 |
| April 05, 2024 | 0.7283 |
| April 04, 2024 | 0.7137 |
| April 03, 2024 | 0.7521 |
| April 02, 2024 | 0.796 |
| April 01, 2024 | 0.8601 |
| March 31, 2024 | |
| March 28, 2024 | 0.9368 |
| March 27, 2024 | 0.9288 |
| March 26, 2024 | 0.901 |
| March 25, 2024 | 0.9467 |
| March 22, 2024 | 0.9726 |
| March 21, 2024 | 1.034 |
| March 20, 2024 | 1.048 |
| March 19, 2024 | 1.042 |
| March 18, 2024 | 1.028 |
| March 15, 2024 | 1.052 |
| March 14, 2024 | 1.038 |
| March 13, 2024 | 1.074 |
| March 12, 2024 | 1.044 |
| March 11, 2024 | 1.070 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5526
Minimum
Apr 18 2024
5.720
Maximum
Jan 07 2021
2.662
Average
2.210
Median
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.3909 |
| Aurinia Pharmaceuticals Inc | 2.180 |
| Edesa Biotech Inc | 3.384 |
| Lexaria Bioscience Corp | 6.225 |
| InMed Pharmaceuticals Inc | 0.1609 |
Price to Book Value Related Metrics
| PS Ratio | 1.545 |
| PEG Ratio | -0.0787 |
| Price | 3.57 |
| Earnings Yield | -30.99% |
| Market Cap | 150.68M |
| PEGY Ratio | -0.0787 |